Evoke Pharma Inc Asset Turnover Ratio (EVOK), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Evoke Pharma Inc   (NASDAQ: EVOK)
 

Evoke Pharma Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Evoke Pharma Inc asset turnover ratio, the ability of Evoke Pharma Inc 's assets to generate revenue in the third quarter 2025, increased sequentially to 0.88 in the third quarter (Sep 30 2025), yet the ratio remained below the average, as EVOK's position remain challenging.

Within sector 99 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2025 compared to the preceding quarter from 1161 to 2414.

Asset Turnover Ratio Definition



EVOK Asset Turnover Ratio (Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
Y / Y Asset Change 10.57 % 32.33 % 31.49 % 147.84 % 80.23 %
Y / Y Revenue Change 61.4 % 47.06 % 77.48 % 97.4 % 69.83 %
Asset Turnover Ratio (TTM) 0.88 0.8 0.77 0.73 0.75
EVOK's Total Ranking # 2414 # 1161 # 966 # 1394 # 2335
Seq. Asset Change -2.56 % -1.93 % -6.52 % 23.78 % 16.62 %
Seq. Revenue Change 14.17 % 21.82 % -6.9 % 24.65 % 4.03 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 100
Healthcare Sector # 341
Overall Market # 2414

Asset Turnover Ratio Statistics
High Average Low
8.96 5.74 4.73
(Sep 30 2021)   (Sep 30 2022)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Biotricity Inc   2.48 $ 14.856  Millions$ 5.986  Millions
Escalon Medical Corp   2.48 $ 11.940  Millions$ 4.819  Millions
Healthcare Services Group Inc   2.24 $ 1,808.303  Millions$ 808.059  Millions
Integrated Biopharma Inc  2.05 $ 52.210  Millions$ 25.440  Millions
Vycor Medical Inc   2.02 $ 1.902  Millions$ 0.940  Millions
Longduoduo Co Ltd  2.01 $ 4.152  Millions$ 2.062  Millions
Biofrontera Inc   2.00 $ 37.165  Millions$ 18.562  Millions
Champions Oncology Inc   1.96 $ 58.424  Millions$ 29.796  Millions
P3 Health Partners Inc   1.94 $ 1,444.952  Millions$ 745.610  Millions
Nature s Sunshine Products inc   1.87 $ 474.009  Millions$ 253.309  Millions
Nuo Therapeutics Inc   1.86 $ 2.612  Millions$ 1.406  Millions
Rosecliff Acquisition Corp I  1.79 $ 24.634  Millions$ 13.752  Millions
Progyny Inc   1.75 $ 1,268.035  Millions$ 723.391  Millions
International Stem Cell Corporation  1.74 $ 9.391  Millions$ 5.406  Millions
Innovage Holding Corp   1.69 $ 884.662  Millions$ 524.629  Millions
Privia Health Group Inc   1.65 $ 2,042.569  Millions$ 1,235.713  Millions
Marpai Inc  1.64 $ 20.702  Millions$ 12.603  Millions
Medinotec Inc   1.63 $ 10.353  Millions$ 6.347  Millions
Option Care Health Inc   1.63 $ 5,532.505  Millions$ 3,398.232  Millions
Talkspace Inc   1.60 $ 214.505  Millions$ 133.692  Millions
Encision Inc   1.60 $ 6.300  Millions$ 3.929  Millions
Iridex Corp  1.60 $ 49.336  Millions$ 30.827  Millions
Electrocore Inc   1.59 $ 28.883  Millions$ 18.121  Millions
Hims and Hers Health Inc   1.55 $ 2,209.484  Millions$ 1,427.534  Millions
Cv Sciences Inc   1.54 $ 11.758  Millions$ 7.658  Millions
Adm Tronics Unlimited Inc   1.52 $ 3.360  Millions$ 2.204  Millions
Qhslab Inc   1.51 $ 2.614  Millions$ 1.728  Millions
Chemed Corporation  1.50 $ 2,530.634  Millions$ 1,684.139  Millions
Kewaunee Scientific Corporation  1.49 $ 286.067  Millions$ 191.591  Millions
Indivior Pharmaceuticals Inc   1.49 $ 2,068.000  Millions$ 1,389.750  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.